Tania Jain, MBBS, discusses the current treatment options for graft-versus-host-disease, a known complication of allogeneic stem cell transplant, which is the only curative treatment option for patients with myelofibrosis.
Tania Jain, MBBS
Articles by Tania Jain, MBBS
Tania Jain, MBBS, discusses the role of ruxolitinib as treatment of graft-versus-host disease.
